Related references
Note: Only part of the references are listed.Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis
Jiawen Zhao et al.
CANCER CELL INTERNATIONAL (2020)
TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
Yuki Tanaka et al.
SCIENTIFIC REPORTS (2020)
Targeting Angiogenesis With Peptide Vaccines
Michal A. Rahat
FRONTIERS IN IMMUNOLOGY (2019)
137PBiomarkers predictive of overall survival in advanced cancer patients treated with a peptide-based cancer vaccine
S Suekane et al.
ANNALS OF ONCOLOGY (2019)
Peptide-based materials for cancer immunotherapy
Lu Zhang et al.
THERANOSTICS (2019)
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour et al.
LANCET ONCOLOGY (2017)
An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy
Masanori Noguchi et al.
CLINICAL CANCER RESEARCH (2016)
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients
Satoru Iwasa et al.
CANCER SCIENCE (2016)
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression
Masanori Noguchi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
A phase II study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
Shoichi Hazama et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine
Aaron J. Schueneman et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
First clinical trial of cancer vaccine therapy with artificially synthesized helper/killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
Norihiko Takahashi et al.
CANCER SCIENCE (2012)
Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Paul Sabbatini et al.
CLINICAL CANCER RESEARCH (2012)
The Present and Future of Peptide Vaccines for Cancer Single or Multiple, Long or Short, Alone or in Combination?
Craig L. Slingluff
CANCER JOURNAL (2011)
Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen-A24 With Recurrent or Progressive Glioblastoma Multiforme
Mizuhiko Terasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
Ninke Leffers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles
M. Naito et al.
BRITISH JOURNAL OF CANCER (2007)
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles
Takafumi Minami et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24+ prostate cancer patients
A Yao et al.
BRITISH JOURNAL OF CANCER (2004)
Identification of epidermal growth factor receptor-derived peptides recognised by both cellular and humoral immune responses in HLA-A24+ non-small cell lung cancer patients
H Shomura et al.
EUROPEAN JOURNAL OF CANCER (2004)
Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases
N Imai et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
M Nakao et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
